BENGALURU, Inde, 25 juin 2024 /PRNewswire/ — Biocon Biologics Ltd (BBL), une société mondiale de biosimilaires totalement intégrée et filiale de Biocon Ltd (code BSE : 532523, NSE : BIOCON), a reçu l’autorisation de l’Agence européenne des médicaments (EMA) pour fabriquer un biosimilaire…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.